Late Breaking Abstract - Oral corticosteroids exposure in a Swedish nationwide asthma population during 2006-2016
Conclusion: By the end of this 9-year observation period, nearly half of all asthma patients in Sweden had been exposed to OCS and one in twenty became a regular user.Sponsor: AstraZeneca
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Nwaru, B., Ekström, M., Wiklund, F., Telg, G., Nordahl, H., Janson, C. Tags: Clinical Problems Source Type: research
More News: Asthma | AstraZeneca | Corticosteroid Therapy | ICD-10 | Prednisolone | Respiratory Medicine | Sweden Health